Skip to content
Open access · CC-BY via OpenAlex

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease

Jamie Toombs, Henrik Zetterberg

Brain Communications · 2020 · ▲ 30 citations

Abstract

This scientific commentary refers to ‘Plasma total-tau, neurofilament light chain and amyloid-β levels and risk of dementia: a population-based study’ by de Wolf et al. (https://doi.org/10.1093/brain/awaa054), and ‘Relationship of amyloid-b1–42 in blood and brain amyloid: Ginkgo Evaluation of Memory Study’ by Lopez et al. (https://doi.org/10.1093/braincomms/fcz038), two papers that illustrate these latest developments.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1093/braincomms/fcaa054
Canonical
link ↗
Fetched
2026-11-05 MST

Cite this

APA
Toombs, J., &amp; Zetterberg, H. (2020). In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease. <em>Brain Communications</em>. https://doi.org/10.1093/braincomms/fcaa054
Vancouver
Toombs J, Zetterberg H. In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease. Brain Communications. 2020. doi:10.1093/braincomms/fcaa054.
BibTeX
@article{jamie2020Intheb, title = {In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease}, author = {Jamie Toombs and Henrik Zetterberg}, journal = {Brain Communications}, year = {2020}, doi = {10.1093/braincomms/fcaa054}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings